Clinical trial
Evaluation of Two Reduced Sirolimus Doses in Treatment of de Novo Coronary…
NCT00233766 · Cordis US Corp., Industry · Completed
Key facts
| NCT number | NCT00233766 |
|---|---|
| Title | Evaluation of Two Reduced Sirolimus Doses in Treatment of de Novo Coronary Artery Lesions (REDOX) |
| Official title | An Evaluation of Two Reduced Sirolimus Doses on the BX VELOCITY Balloon-Expandable Stent in the Treatment of Patients With de Novo Native Coronary Artery Lesions(REDOX) |
| Lead sponsor | Cordis US Corp., Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Device |
| Interventions | Bx VELOCITY Stent containing 45% and 70% of Sirolimus dose |
| Enrollment | 60 |
| Start date | Sep 1, 2002 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Oct 6, 2005 |
| Last update posted | Apr 24, 2008 |
| Countries | Brazil |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: